Publicaciones en las que colabora con Francisco J. Bermúdez Jiménez (31)

2024

  1. Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome

    Circulation Research, Vol. 134, Núm. 8, pp. E52-E71

  2. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

2023

  1. A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120

  2. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 301-311

  3. Selection of the best of 2022 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 58, pp. S68-S73

2022

  1. Antiarrhythmic effect of sacubitril/valsartan in high arrhythmic risk inherited cardiomyopathies

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 219-221

  2. Initial experience with left bundle branch area pacing in patients with transthyretin cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 182-185

  3. Monomorphic and Polymorphic Ventricular Arrhythmias in Heterozygous Calsequestrin-2 Mutation Carriers

    Circulation. Genomic and precision medicine, Vol. 15, Núm. 2, pp. e003518

  4. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  5. Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

    Medicina Clinica, Vol. 158, Núm. 12, pp. 569-575

  6. Selection of the best of 2021 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 57, pp. S54-S59

2021

  1. Association of Left Ventricular Systolic Dysfunction among Carriers of Truncating Variants in Filamin C with Frequent Ventricular Arrhythmia and End-stage Heart Failure

    JAMA Cardiology, Vol. 6, Núm. 8, pp. 891-901

  2. Heterozygous arrhythmogenic cardiomyopathy-desmoplakin mutation carriers exhibit a subclinical cutaneous phenotype with cell membrane disruption and lack of intercellular adhesion

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  3. Layer-Specific Global Longitudinal Strain Predicts Arrhythmic Risk in Arrhythmogenic Cardiomyopathy

    Frontiers in Cardiovascular Medicine, Vol. 8

  4. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy

    European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286

  5. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224

  6. To the Editor—Mexiletine in myotonic dystrophy: Beware of ventricular arrhythmias!

    Heart Rhythm

2020

  1. Absence of relevant QT interval prolongation in not critically ill COVID-19 patients

    Scientific Reports, Vol. 10, Núm. 1

  2. Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement

    Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 554-560

  3. Cardiac magnetic resonance in arrhythmogenic cardiomyopathy: is it time to update the 2010 criteria?

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 871-873